Trial 26866138MMY3022

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

26866138MMY3022

Full title

Randomisierte Phase-III-Studie zu Bortezomib und niedrig dosiertem Dexamethason mit oder ohne kontinuierliches niedrig dosiertes orales Cyclophosphamid bei primär refraktärem oder rezidiviertem multiplem Myelom

EudraCT number

2008-003213-27

Responsible organization

Medizinische Klinik III, Telefon: 089440072551 Lmu

Indications

Classification	Code	Description
ICD-10-GM	C90.0-	Multiples Myelom
-		Bloodcancer (leukemia, lymphoma)

Trial design

Trial type

Interventional

Phase

III

Status

Recruitment finished

Votes

Institutional review board - vote

Unknown

Initiiation & lock

Date of lock (planned / actual)

Unknown / Unknown

Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.